Abstract: The invention relates to a novel sweet-tasting refreshing beverage, which is free of phosphoric acid and instead contains at least 0.3% by weight/volume of gluconic acid, which is low in minerals, specifically contains less than 250 mg/liter of minerals, which is low in sugar, specifically contains at most 2.5% by weight/volume of sugar, wherein these sugars comprise at least 10% weight/weight galactose and in addition a proportion of isomaltulose and/or tagatose, and which has a glycemic index of at most 35 (GI<35).
Abstract: The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer.
Type:
Grant
Filed:
May 19, 2015
Date of Patent:
December 4, 2018
Assignee:
AMAZONIA FITOMEDICAMENTOS LTDA.
Inventors:
Luiz F. Pianowski, Claudio P. Chaves, Joao B. Calixto
Abstract: A method for treating liver fibrosis. The method includes administering to a subject suffering from liver fibrosis a pharmaceutically active extract obtained from a Boehmeria species. Also disclosed is a method for regenerating liver tissue and a method for improving a liver function.
Type:
Grant
Filed:
November 22, 2013
Date of Patent:
November 27, 2018
Assignee:
Industrial Technology Research Institute
Abstract: The present invention relates to a composition of phenolic antioxidants obtained from oil palm, and more particularly this invention relates to a composition for promoting immunity in general and most essentially against Human Immunodeficiency Virus (HIV) related infections. Accordingly, the composition having the said oil palm compounds can effectively inhibit various viruses, further supporting oil palm compounds as one of the broad spectrum antiviral drugs.
Type:
Grant
Filed:
October 1, 2012
Date of Patent:
November 20, 2018
Assignee:
Malaysian Palm Oil Board
Inventors:
Ravigadevi Sambanthamurthi, Kalyana Sundram P. Manickam, Yew Ai Tan, Mohd Basri bin Wahid
Abstract: A method for preparing a concentrated extract of Harpagophytum procumbens, in liquid or dry form, having a harpagoside titer greater than or equal to 5%, comprises a step of purifying a crude extract of Harpagophytum procumbens in liquid form in aqueous phase by a technique of liquid-liquid extraction with an organic solvent selected from the esters.
Abstract: The present invention provides a preparation method of tea water comprising the following steps of: inactivating enzymes of raw tea leaves and juicing the tea leaves to obtain a tea juice; and removing ions of the tea juice obtained from the previous step to obtain tea water. In addition, the present invention provides tea water obtained by removing ions from a tea juice of raw tea leaves of which enzymes are inactivated. Skin-stimulating components are reduced in the tea water.
Type:
Grant
Filed:
September 29, 2014
Date of Patent:
October 30, 2018
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Chan S. Rha, Yu J. Oh, Jin O. Chung, Se J. Yoo, Sang J. Lee
Abstract: The invention discloses herbal ingredients derived from Sphaeranthus indicus standardized to at least one frullanolide/eudesmanoid sesquiterpene compound and their compositions as natural energy enhancer to provide an onset and steady maintenance of energy and mental alertness in a mammal. The invention further includes the use of ingredients and compositions for food ingredient formulations such as dietary supplement, food ingredient, beverage, snack or energy drink containing the above said herbal ingredient(s) for enhancing physical activity, physical fitness, mental alertness, enhancing energy levels, stamina levels, circulatory health, blood vessel health and for better mental health in warm blooded animal.
Abstract: A persimmon leaf-derived polysaccharide fraction consisting of 60-80 wt % of neutral sugar and 18-39 wt % of uronic acid, and 0.5-10 wt % of 3-deoxy-D-manno-2-octulosonic acid (KDO) analogs, the wt % based on the total weight of the polysaccharide fraction.
Type:
Grant
Filed:
September 30, 2015
Date of Patent:
October 23, 2018
Assignees:
KOREA FOOD RESEARCH INSTITUTE, Kyonggi University Industry & Academy Cooperation Foundation
Inventors:
Hee-Do Hong, Young-Chul Lee, Chang-Won Cho, Young-Kyoung Rhee, Young-Chan Kim, Su Kyung Sung, Hee Jung Kim, Kwang-Soon Shin, Hye-Ryung Park, Sun Young Jo
Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.
Type:
Grant
Filed:
May 9, 2014
Date of Patent:
October 2, 2018
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Chan-Woong Park, Myeong Hoon Yeom, Nam Hoon Cho, Sang Jun Lee, Sang Min Lee, Jin Young Lee, Hee Yong Jeon, Young-Myeong Kim, Chun-Ki Kim, Young Deuk Choi
Abstract: The invention relates compositions and methods for treating pathological lung conditions using whole-grain flaxseed or flaxseed lignans. Specifically, the invention relates to the dietary use of flaxseed lignans.
Type:
Grant
Filed:
April 11, 2011
Date of Patent:
August 14, 2018
Assignee:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Abstract: Methods of treating inflammation, pain or both inflammation and pain in a subject are provided. The method includes the step of administering a human birth tissue material composition on or within an affected site of a body. The methods are particularly suitable for treatment of inflammation, pain or both inflammation and pain arising from a viral infection.
Abstract: The present invention relates to a novel sebum secretion inhibitor and use thereof for the production of cosmetic and pharmaceutical, notably dermatological, compositions, intended for preventing and/or reducing the secretion of sebum and notably of squalene.
Type:
Grant
Filed:
November 23, 2009
Date of Patent:
July 10, 2018
Assignee:
BASF Beauty Care Solutions France S.A.S.
Abstract: The method of making an Ajwa date-based treatment for snake envenomation is a method for preparing a composition for the treatment of local hemorrhage and edema induced by snake envenomation. The composition is an ethanolic extract of the fruit of the Ajwa date palm (Phoenix dactylifera L.). A concentrated, granulated extract of the Ajwa date is produced by repeated suspension in ethanol, extraction, filtering, and drying the filtrate to evaporate the solvent. The final filtrate is lyophilized (i.e., freeze-dried) to yield a granulated Ajwa date-based treatment for snake envenomation. This granulated Ajwa date-based treatment for snake envenomation may then be further suspended in a saline solution for preparation of an intravenous treatment for snake envenomation.
Type:
Grant
Filed:
May 25, 2017
Date of Patent:
June 26, 2018
Assignee:
SULTAN QABOOS UNIVERSITY
Inventors:
Sidgi S. A. A. Hasson, Ali A. H. Al Jabri
Abstract: The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant.
Abstract: A method and an apparatus of extracting lipids from microalgae are provided. In the method, pressurized carbon dioxide (CO2) is dissolved in a liquid alcohol to form a CO2-expanded alcohol solution at a pressure of about 400-1500 psi and a temperature of about 30-65° C. Next, the CO2-expanded alcohol solution contacts microalgae to extract the lipids from the microalgae. A method and an apparatus of preparing fatty acid esters from microalgae are disclosed as well.
Abstract: Suggested are new extracts of microalgae selected from the group consisting of (i) Monodus sp. (ii) Thalassiosira sp. (iii) Chaetoceros sp. and/or (iv) Chlorococcum sp. obtainable by treating said microalgae with a solvent selected from the group consisting of C1-C4 aliphatic alcohols, ethyl acetate, water or their mixtures, removing the dissolved extracts from the residues and recovering the pure extracts from the solvent. The extracts show excellent properties particularly in modulating the metabolism of human skin and hair follicles.
Type:
Grant
Filed:
October 13, 2011
Date of Patent:
May 22, 2018
Assignee:
Cutech S.r.L.
Inventors:
Lorenzo Zanella, Paolo Pertile, Michele Massironi, Marco Massironi, Elisa Caviola
Abstract: Novel safflower oil emulsion and method of preparation. The safflower oil is 100% all natural, non-genetically modified organism (GMO), expeller pressed, solvent free, linoleic fatty acid rich oil wherein the linoleic fatty acid content is in a range from approximately 70% to approximately 80% of the total safflower oil that is mixed with a purified water and a mixture of at least one of an emulsifier, a flavoring, a natural sweetener, a natural coloring agent, and a gum. The mixture is blended to provide a stable emulsion that has the rich taste of a nutritious fruit smoothie that increases metabolism to support a healthy weight management program. The resulting dietary supplement is bioavailable and easily absorbed by the consumer of the emulsified safflower oil dietary supplement.
Abstract: The present invention relates to a composition containing Horse chestnut extract that inhibits angiogenesis and matrix metalloproteinase activity. The Horse chestnut extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat and prevent disease related to angiogenesis and/or matrix metalloproteinase.
Type:
Grant
Filed:
April 26, 2004
Date of Patent:
May 8, 2018
Assignee:
Angiolab, Inc.
Inventors:
Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park, Kyoung-Mi Kim
Abstract: Formulations to treat skin discoloration via a multi-modal approach are provided in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. An example formulation includes a first anti-melanin agent, a second anti-melanin agent, an anti-inflammatory agent, a sun protection agent, and an anti-oxidant. In one aspect, the first anti-melanin agent comprises a bidens pilosa extract, the second anti-melanin agent comprises a rheum rhaponticum extract, the anti-inflammatory agent comprises a Vitamin E compound, the sun protection agent comprises zinc oxide and titanium dioxide, and the antioxidant comprises a thermus thermophilus ferment extract.